Dapsone in the Management of Autoimmune Bullous Diseases

Dermatologic Clinics

Volumn 29, Issue 4, 2011, Pages 561-564

  Piette, Evan W ^a   Werth, Victoria P ^a,b  

^a Perelman Center for Advanced Medicine   (United States)

^b Philadelphia VA Medical Center   (United States)

Author keywords

Autoimmune bullous disease; Dapsone; Review

Indexed keywords

AZATHIOPRINE; COLCHICINE; CYCLOPHOSPHAMIDE; DAPSONE; METHOTREXATE; MYCOPHENOLIC ACID; NICOTINAMIDE; PLACEBO; PREDNISONE; TETRACYCLINE;

ADD ON THERAPY; AGRANULOCYTOSIS; ANEMIA; AUTOIMMUNE BULLOUS DISEASE; BULLOUS PEMPHIGOID; BULLOUS SKIN DISEASE; DERMATITIS HERPETIFORMIS; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EPIDERMOLYSIS BULLOSA ACQUISITA; GLUTEN FREE DIET; HEMOLYSIS; HUMAN; LINEAR IMMUNOGLOBULIN A BULLOUS DERMATOSIS; LOW DRUG DOSE; METHEMOGLOBINEMIA; MUCOUS MEMBRANE PEMPHIGOID; PATIENT MONITORING; PEMPHIGUS FOLIACEUS; PEMPHIGUS VULGARIS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SKIN DISEASE; SKIN LUPUS ERYTHEMATOSUS; URINALYSIS;

AUTOIMMUNE DISEASES; DAPSONE; DERMATOLOGIC AGENTS; FEMALE; FOLIC ACID ANTAGONISTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SKIN DISEASES, VESICULOBULLOUS;

EID: 80052912573     PISSN: 07338635     EISSN: 15580520     Source Type: Journal    
DOI: 10.1016/j.det.2011.06.018     Document Type: Review

References (41)

1. Zhu Y.I., Stiller M.J. Dapsone and sulfones in dermatology: overview and update. J Am Acad Dermatol 2001, 45(3):420-434.
2. Mutasim D.F. Therapy of autoimmune bullous diseases. Ther Clin Risk Manag 2007, 3(1):29-40.
3. Winkelmann R.K., Roth H.L. Dermatitis herpetiformis with acantholysis or pemphigus with response to sulfonamides: report of two cases. Arch Dermatol 1960, 82:385-390.
4. Werth V.P., Fivenson D., Pandya A.G., et al. Multicenter randomized, double-blind, placebo-controlled, clinical trial of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris. Arch Dermatol 2008, 144(1):25-32.
5. Martin L.K., Werth V., Villanueva E., et al. Interventions for pemphigus vulgaris and pemphigus foliaceus. Cochrane Database Syst Rev 2009, 1. CD006263.
6. Gürcan H.M., Ahmed A.R. Efficacy of dapsone in the treatment of pemphigus and pemphigoid: analysis of current data. Am J Clin Dermatol 2009, 10(6):383-396.
7. Basset N., Guillot B., Michel B., et al. Dapsone as initial treatment in superficial pemphigus. Report of nine cases. Arch Dermatol Jun 1987, 123(6):783-785.
8. Kirtschig G., Middleton P., Bennett C., et al. Interventions for bullous pemphigoid. Cochrane Database Syst Rev 2010, 10. CD002292.
9. Foster C.S. Cicatricial pemphigoid. Trans Am Ophthalmol Soc 1986, 84:527-663.
10. Kirtschig G., Murrell D., Wojnarowska F., et al. Interventions for mucous membrane pemphigoid/cicatricial pemphigoid and epidermolysis bullosa acquisita: a systematic literature review. Arch Dermatol 2002, 138(3):380-384.
11. Walling H.W., Sontheimer R.D. Cutaneous lupus erythematosus: issues in diagnosis and treatment. Am J Clin Dermatol 2009, 10(6):365-381.
12. Aboobaker J., Ramsaroop R., Abramowitz I., et al. Bullous systemic erythematosus. A case report. S Afr Med J 1986, 69(1):49-51.
13. Alarcon G.S., Sams W.M., Barton D.D., et al. Bullous lupus erythematosus rash worsened by dapsone. Arthritis Rheum 1984, 27(9):1071-1072.
14. Burrows N.P., Bhogal B.S., Black M.M., et al. Bullous eruption of systemic lupus erythematosus: a clinicopathological study of four cases. Br J Dermatol 1993, 128(3):332-338.
15. Fujimoto W., Hamada T., Yamada J., et al. Bullous systemic lupus erythematosus as an initial manifestation of SLE. J Dermatol 2005, 32(12):1021-1027.
16. Hall R.P., Lawley T.J., Smith H.R., et al. Bullous eruption of systemic lupus erythematosus. Dramatic response to dapsone therapy. Ann Intern Med 1982, 97(2):165-170.
17. Ludgate M.W., Greig D.E. Bullous systemic lupus erythematosus responding to dapsone. Australas J Dermatol 2008, 49(2):91-93.
18. Prystowsky J.H., Finkel L., Tar L., et al. Bullous eruption in a woman with lupus erythematosus. Bullous systemic lupus erythematosus (SLE). Arch Dermatol 1988, 124(4):571. 574-5.
19. Shirahama S., Yagi H., Furukawa F., et al. A case of bullous systemic lupus erythematosus. Dermatology 1994, 189(Suppl 1):95-96.
20. Sirka C.S., Padhi T., Mohanty P., et al. Bullous systemic lupus erythematosus: response to dapsone in two patients. Indian J Dermatol Venereol Leprol 2005, 71(1):54-56.
21. Tani M., Shimizu R., Ban M., et al. Systemic lupus erythematosus with vesiculobullous lesions. Immunoelectron microscopic studies. Arch Dermatol 1984, 120(11):1497-1501.
22. Tay Y.K., Wong S.N., Tan T. Bullous systemic lupus erythematosus-a case report and review. Ann Acad Med Singapore 1995, 24(6):879-882.
23. Yung A., Oakley A. Bullous systemic lupus erythematosus. Australas J Dermatol 2000, 41(4):234-237.
24. Ishii N., Hamada T., Dainichi T., et al. Epidermolysis bullosa acquisita: what's new?. J Dermatol 2010, 37(3):220-230.
25. Hughes A.P., Callen J.P. Epidermolysis bullosa acquisita responsive to dapsone therapy. J Cutan Med Surg 2001, 5(5):397-399.
26. Luke M.C., Darling T.N., Hsu R., et al. Mucosal morbidity in patients with epidermolysis bullosa acquisita. Arch Dermatol 1999, 135(8):954-959.
27. Taniuchi K., Inaoki M., Nishimura Y., et al. Nonscarring inflammatory epidermolysis bullosa acquisita with esophageal involvement and linear IgG deposits. J Am Acad Dermatol 1997, 36(2 Pt 2):320-322.
28. Rappersberger K., Konrad K., Schenk P., et al. Hautarzt 1988, 39(6):355-362. [in German].
29. Megahed M., Scharffetter-Kochanek K. Epidermolysis bullosa acquisita-successful treatment with colchicine. Arch Dermatol Res 1994, 286(1):35-46.
30. Cunningham B.B., Kirchmann T.T., Woodley D. Colchicine for epidermolysis bullosa acquisita. J Am Acad Dermatol 1996, 34(5 Pt 1):781-784.
31. Caproni M., Antiga E., Melani L., et al. Guidelines for the diagnosis and treatment of dermatitis herpetiformis. J Eur Acad Dermatol Venereol 2009, 23(6):633-638.
32. Garioch J.J., Lewis H.M., Sargent S.A., et al. 25 years' experience of a gluten-free diet in the treatment of dermatitis herpetiformis. Br J Dermatol 1994, 131(4):541-545.
33. Alexander J.O. Dapsone in the treatment of dermatitis herpetiformis. Lancet 1955, 268(6876):1201-1202.
34. Morgan J.K., Marsden C.W., Coburn J.G., et al. Dapsone in dermatitis herpetiformis. Lancet 1955, 268(6876):1197-1200.
35. DeMento F.J., Grover R.W. Acantholytic herpetiform dermatitis. Arch Dermatol 1973, 107(6):883-887.
36. Junkins-Hopkins J.M. Dermatitis herpetiformis: pearls and pitfalls in diagnosis and management. J Am Acad Dermatol 2010, 63(3):526-528.
37. Egan C.A., Zone J.J. Linear IgA bullous dermatosis. Int J Dermatol 1999, 38(11):818-827.
38. Provost T.T., Maize J.C., Ahmed A.R., et al. Unusual subepidermal bullous diseases with immunologic features of bullous pemphigoid. Arch Dermatol 1979, 115(2):156-160.
39. Wojnarowska F. Linear IgA dapsone responsive bullous dermatosis. J R Soc Med 1980, 73(5):371-373.
40. Long S.A., Argenyi Z.B., Piette W.W. Arciform blistering in an elderly woman. Linear IgA dermatosis (LAD). Arch Dermatol 1988, 124(11):1705. 1708.
41. Patricio P., Ferreira C., Gomes M.M., et al. Autoimmune bullous dermatoses: a review. Ann N Y Acad Sci 2009, 1173:203-210.